BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30769115)

  • 21. Calcium dobesilate for diabetic retinopathy: a systematic review and meta-analysis.
    Zhang X; Liu W; Wu S; Jin J; Li W; Wang N
    Sci China Life Sci; 2015 Jan; 58(1):101-7. PubMed ID: 25528255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy.
    Benarroch IS; Brodsky M; Rubinstein A; Viggiano C; Salama EA
    Ophthalmic Res; 1985; 17(3):131-8. PubMed ID: 4011126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angioprotective action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat.
    Brunet J; Farine JC; Garay RP; Hannaert P
    Eur J Pharmacol; 1998 Oct; 358(3):213-20. PubMed ID: 9822887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function.
    Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z
    Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcium dobesilate in diabetic retinopathy. A retrospective controlled study.
    Adank C; Koerner F
    Ophthalmologica; 1985; 190(2):102-11. PubMed ID: 3982791
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of calcium dobesilate on blood viscosity in diabetic microangiopathy. A review.
    Barras JP; Michal M
    Vasa; 1986; 15(3):200-5. PubMed ID: 3532608
    [No Abstract]   [Full Text] [Related]  

  • 27. Can calcium dobesilate be used safely for peripheral microvasculopathies that require neoangiogenesis?
    Demirtas S; Caliskan A; Guclu O; Yazici S; Karahan O; Yavuz C; Mavitas B
    Med Sci Monit Basic Res; 2013 Sep; 19():253-7. PubMed ID: 24072135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modern approach to early diagnosis and pathogenetic treatment of diabetic retinopathy].
    Vorob'eva IV
    Vestn Oftalmol; 2016; 132(5):60-67. PubMed ID: 27911427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.
    Ribeiro ML; Seres AI; Carneiro AM; Stur M; Zourdani A; Caillon P; Cunha-Vaz JG;
    Graefes Arch Clin Exp Ophthalmol; 2006 Dec; 244(12):1591-600. PubMed ID: 16763797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of calcium dobesilate on blood hyperviscosity].
    Fortschr Med; 1979 Mar; 97(9):422. PubMed ID: 428880
    [No Abstract]   [Full Text] [Related]  

  • 31. Calcium dobesilate for prevention of gentamicin-induced nephrotoxicity in rats.
    Jafarey M; Changizi Ashtiyani S; Najafi H
    Iran J Kidney Dis; 2014 Jan; 8(1):46-52. PubMed ID: 24413721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of calcium dobesilate in chronic venous disease, diabetic retinopathy and haemorrhoids.
    Allain H; Ramelet AA; Polard E; Bentué-Ferrer D
    Drug Saf; 2004; 27(9):649-60. PubMed ID: 15230646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Calcium dobesilate may improve hemorheology in patients undergoing coronary artery bypass grafting.
    Besirli K; Aydemir B; Arslan C; Kiziler AR; Canturk E; Kayhan B
    Rev Bras Cir Cardiovasc; 2012; 27(2):260-6. PubMed ID: 22996977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effects of calcium dobesilate on the mechanical function of rat hearts.
    Cihan Ozbek I; Arslan C; Cantürk E; Süzer O
    J Cardiovasc Surg (Torino); 2009 Jun; 50(3):395-401. PubMed ID: 19543197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [5 years experimentation with calcium dobesilate in the treatment of retinopathies].
    Sévin R; Cuendet J-F
    Ophthalmologica; 1975; 170(2-3):232-8. PubMed ID: 1134739
    [No Abstract]   [Full Text] [Related]  

  • 36. The value of calcium dobesilate in the treatment of diabetic retinopathy. A controlled clinical trial.
    Larsen HW; Sander E; Hoppe R
    Diabetologia; 1977 Apr; 13(2):105-9. PubMed ID: 323093
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of sorbitol formation in human erythrocytes by calcium dobesilate.
    Schmidt M; Michal M
    Arzneimittelforschung; 1989 Apr; 39(4):493-5. PubMed ID: 2502128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcium dobesilate: pharmacology and future approaches.
    Tejerina T; Ruiz E
    Gen Pharmacol; 1998 Sep; 31(3):357-60. PubMed ID: 9703201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Calcium dobesilate may alleviate diabetes‑induced endothelial dysfunction and inflammation.
    Zhou Y; Yuan J; Qi C; Shao X; Mou S; Ni Z
    Mol Med Rep; 2017 Dec; 16(6):8635-8642. PubMed ID: 29039485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of calcium bodesilate (doxium) on circulatory disorders of the retina with special emphasis on diabetic retinopathy.
    Németh B; Hudomel J; Farkas A
    Ophthalmologica; 1975; 170(5):434-45. PubMed ID: 1153166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.